Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study finds 81% of cancer cures touted by TikTok videos are fake

2.

Dual imaging capsule captures 3D tissue and blood vessel changes for early esophageal cancer diagnosis

3.

Decrease seen in in situ breast cancer since 2009

4.

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

5.

Housing aid linked to lower medical financial hardship among US renters with cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot